About Icons

Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

Drug Description in Trials / DrugBank / KEGG DRUG

Search results

No.

Drug (Description in trials)

DrugBank

KEGG DRUG

KEGG GENES

KEGG PATHWAY

Disease ID

1

-

-

-

-

[4] 11, 62, 66, 109 💬

2

-

-

-

-

[7] 2, 11, 13, 50, 62, 66, 109 💬

3

ANTI-C5 antibody

-

-

-

-

[4] 11, 14, 62, 109 💬

4

C5 INH MAB, SKY59, RO/CH7092230

-

-

-

-

[2] 62, 109 💬

5

-

-

-

-

[6] 43, 44, 49, 66, 109, 222 💬

6

-

-

-

[4] 11, 62, 66, 109 💬

7

[1] Nomacopan 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[2] 62, 109 💬

8

[1] Crovalimab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[2] 62, 109 💬

9

[1] Eculizumab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[8] 11, 13, 14, 61, 62, 109, 221, 222 💬

Disease ID	Name
11	Myasthenia gravis
13	Multiple sclerosis
14	Chronic inflammatory demyelinating polyneuropathy
61	Autoimmune hemolytic anemia
62	Paroxysmal nocturnal hemoglobinuria
109	Atypical hemolytic uremic syndrome
221	Anti-glomerular basement membrane disease
222	Primary nephrotic syndrome

10

FC- and CDR-modified humanised monoclonal antibody against C5

-

-

-

-

[3] 11, 62, 109 💬

11

[2] Iptacopan ,
Iptacopan hydrochloride 💬

[1] CFB 💬

[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬

[6] 11, 61, 62, 66, 109, 222 💬

12

Iptacopan hydrochloride

[2] Iptacopan ,
Iptacopan hydrochloride 💬

[1] CFB 💬

[3] Complement and coagulation cascades, Coronavirus disease - COVID-19, Staphylococcus aureus infection 💬

[4] 61, 66, 109, 222 💬

13

Iptcaopan 200 MG

-

-

-

-

[1] 109 💬

14

-

-

-

-

[5] 61, 62, 66, 109, 222 💬

15

-

-

-

-

[4] 50, 62, 66, 109 💬

16

OMS00620646, OMS620646, MASP-2 antibody

-

-

-

-

[1] 109 💬

17

-

-

-

-

[4] 64, 66, 109, 222 💬

18

OMS721 100 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody

-

-

-

-

[2] 64, 109 💬

19

OMS721 185 MG/ML injection solution, OMS00620646, OMS620646, MASP-2 antibody

-

-

-

-

[2] 64, 109 💬

20

OMS721 drug product 185 MG/ML

-

-

-

-

[1] 109 💬

21

[1] Ravulizumab

[1] Ravulizumab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[7] 2, 11, 13, 50, 62, 66, 109 💬

22

RO7112689/F03-01

-

-

-

-

[2] 62, 109 💬

23

RO7112689/F03-10

-

-

-

-

[2] 62, 109 💬

24

-

-

-

-

[3] 62, 109, 162 💬

25

-

-

-

-

[2] 62, 109 💬

26

[1] Eculizumab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[6] 11, 13, 14, 62, 109, 222 💬

Disease ID	Name
11	Myasthenia gravis
13	Multiple sclerosis
14	Chronic inflammatory demyelinating polyneuropathy
62	Paroxysmal nocturnal hemoglobinuria
109	Atypical hemolytic uremic syndrome
222	Primary nephrotic syndrome

27

Soliris 300 MG concentrado para solucióN para perfusióN

[1] Eculizumab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[1] 109 💬

28

Soliris 300 MG solution à diluer pour perfusion

[1] Eculizumab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[1] 109 💬

29

[1] Ravulizumab

[1] Ravulizumab 💬

[1] C5 💬

[11] Alcoholic liver disease, Complement and coagulation cascades, Coronavirus disease - COVID-19, Herpes simplex virus 1 infection, Neuroactive ligand-receptor interaction, Neutrophil extracellular trap formation, Pertussis, Prion disease, Regulation of actin cytoskeleton, Staphylococcus aureus infection, Systemic lupus erythematosus 💬

[7] 2, 11, 13, 50, 62, 66, 109 💬